NOVONIX Ltd Files Form 6-K for September 2024

Ticker: NVNXF · Form: 6-K · Filed: Sep 10, 2024 · CIK: 1859795

Sentiment: neutral

Topics: sec-filing, foreign-private-issuer, reporting-update

TL;DR

NOVONIX filed a 6-K, confirming foreign private issuer status and 20-F reporting.

AI Summary

NOVONIX Limited filed a Form 6-K on September 10, 2024, reporting for the month of September 2024. The filing indicates that NOVONIX is a foreign private issuer and will file its annual reports under Form 20-F. The company's principal executive office is located in Brisbane, Australia.

Why It Matters

This filing serves as an update for investors regarding NOVONIX's reporting status as a foreign private issuer and its adherence to SEC regulations.

Risk Assessment

Risk Level: low — This filing is a routine procedural report and does not contain new financial or operational information that would typically indicate increased risk.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.

What does it mean that NOVONIX is a 'foreign private issuer'?

It means NOVONIX is a foreign entity that is not a U.S. government entity and is considered 'foreign' under SEC rules, allowing it to use certain forms and exemptions from U.S. securities laws, such as filing annual reports on Form 20-F instead of Form 10-K.

Which annual report form will NOVONIX file?

NOVONIX will file its annual reports under cover of Form 20-F.

Where is NOVONIX's principal executive office located?

NOVONIX's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.

What is the SEC filing number for NOVONIX?

The SEC file number for NOVONIX is 001-41208.

Filing Stats: 196 words · 1 min read · ~1 pages · Grade level 13.1 · Accepted 2024-09-10 09:27:35

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: September 10, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing